Published in Curr Top Microbiol Immunol on January 01, 1995
Recovery of divergent avian bornaviruses from cases of proventricular dilatation disease: identification of a candidate etiologic agent. Virol J (2008) 2.69
Genome trimming: a unique strategy for replication control employed by Borna disease virus. Proc Natl Acad Sci U S A (2005) 1.61
Borna disease virus-induced neurological disorder in mice: infection of neonates results in immunopathology. J Virol (1998) 1.35
Characterization of Borna disease virus p56 protein, a surface glycoprotein involved in virus entry. J Virol (1997) 1.33
N-terminal domain of Borna disease virus G (p56) protein is sufficient for virus receptor recognition and cell entry. J Virol (2001) 1.32
Detection of Borna disease virus (BDV) antibodies and BDV RNA in psychiatric patients: evidence for high sequence conservation of human blood-derived BDV RNA. J Virol (1996) 1.29
MEK-specific inhibitor U0126 blocks spread of Borna disease virus in cultured cells. J Virol (2001) 1.16
A functional role for neutralizing antibodies in Borna disease: influence on virus tropism outside the central nervous system. J Virol (1998) 1.15
Alpha/beta interferon promotes transcription and inhibits replication of borna disease virus in persistently infected cells. J Virol (2001) 1.14
Biochemical and functional analysis of the Borna disease virus G protein. J Virol (1997) 1.12
T cell ignorance in mice to Borna disease virus can be overcome by peripheral expression of the viral nucleoprotein. Proc Natl Acad Sci U S A (1999) 1.08
Molecular basis for the differential subcellular localization of the 38- and 39-kilodalton structural proteins of Borna disease virus. J Virol (1997) 1.07
Borna disease virus infection in animals and humans. Emerg Infect Dis (1997) 1.07
Inhibition of Borna disease virus replication by ribavirin. J Virol (1999) 1.05
Pathogenesis of borna disease virus: granulocyte fractions of psychiatric patients harbor infectious virus in the absence of antiviral antibodies. J Virol (1999) 1.05
The nucleolus is the site of Borna disease virus RNA transcription and replication. J Virol (1998) 1.04
Sequence variability of Borna disease virus open reading frame II found in human peripheral blood mononuclear cells. J Virol (1996) 1.03
Avian bornavirus associated with fatal disease in psittacine birds. J Virol (2010) 1.03
A preliminary study of viral metagenomics of French bat species in contact with humans: identification of new mammalian viruses. PLoS One (2014) 1.02
Induction of degenerative brain lesions after adoptive transfer of brain lymphocytes from Borna disease virus-infected rats: presence of CD8+ T cells and perforin mRNA. J Virol (1997) 1.01
Chemokine gene expression in astrocytes of Borna disease virus-infected rats and mice in the absence of inflammation. J Virol (2000) 1.00
Virus-specific CD4+ T cells eliminate borna disease virus from the brain via induction of cytotoxic CD8+ T cells. J Virol (1998) 0.98
Borna disease. Emerg Infect Dis (1997) 0.98
Glial expression of Borna disease virus phosphoprotein induces behavioral and neurological abnormalities in transgenic mice. Proc Natl Acad Sci U S A (2003) 0.97
Borna disease virus and human disease. Clin Microbiol Rev (2001) 0.97
Expression and characterization of the Borna disease virus polymerase. J Virol (2000) 0.96
Borna disease virus phosphoprotein binds a neurite outgrowth factor, amphoterin/HMG-1. J Virol (2001) 0.96
CD8 T cells require gamma interferon to clear borna disease virus from the brain and prevent immune system-mediated neuronal damage. J Virol (2005) 0.94
Borna disease in a dog with lethal meningoencephalitis. J Clin Microbiol (1998) 0.94
Borna disease virus nucleoprotein (p40) is a major target for CD8(+)-T-cell-mediated immune response. J Virol (1999) 0.94
Identification of host factors involved in borna disease virus cell entry through a small interfering RNA functional genetic screen. J Virol (2010) 0.94
Pathogenesis of avian bornavirus in experimentally infected cockatiels. Emerg Infect Dis (2012) 0.93
A reverse-type sandwich enzyme-linked immunosorbent assay for detecting antibodies to Borna disease virus. J Clin Microbiol (1997) 0.92
Cell-to-cell spread of Borna disease virus proceeds in the absence of the virus primary receptor and furin-mediated processing of the virus surface glycoprotein. J Virol (2007) 0.91
Modulation of Borna disease virus phosphoprotein nuclear localization by the viral protein X encoded in the overlapping open reading frame. J Virol (2003) 0.90
Transgenic mice expressing the nucleoprotein of Borna disease virus in either neurons or astrocytes: decreased susceptibility to homotypic infection and disease. J Virol (2004) 0.90
Enhanced neurovirulence of borna disease virus variants associated with nucleotide changes in the glycoprotein and L polymerase genes. J Virol (2002) 0.89
Molecular chaperone BiP interacts with Borna disease virus glycoprotein at the cell surface. J Virol (2009) 0.89
Identification of the immunodominant H-2K(k)-restricted cytotoxic T-cell epitope in the Borna disease virus nucleoprotein. J Virol (2001) 0.89
Borna disease virus infects human neural progenitor cells and impairs neurogenesis. J Virol (2011) 0.88
Borna disease virus requires cholesterol in both cellular membrane and viral envelope for efficient cell entry. J Virol (2009) 0.87
Downregulation of an astrocyte-derived inflammatory protein, S100B, reduces vascular inflammatory responses in brains persistently infected with Borna disease virus. J Virol (2007) 0.87
Characterization of the Borna disease virus phosphoprotein, p23. J Virol (1996) 0.87
Effect of immune priming on Borna disease. J Virol (1999) 0.86
Borna disease virus multiplication in mouse organotypic slice cultures is site-specifically inhibited by gamma interferon but not by interleukin-12. J Virol (2004) 0.86
Evolutionarily conserved interaction between the phosphoproteins and X proteins of bornaviruses from different vertebrate species. PLoS One (2012) 0.85
CD8(+) T lymphocytes mediate Borna disease virus-induced immunopathology independently of perforin. J Virol (2001) 0.85
Borna disease virus nucleoprotein interacts with the CDC2-cyclin B1 complex. J Virol (2003) 0.85
Borna disease virus accelerates inflammation and disease associated with transgenic expression of interleukin-12 in the central nervous system. J Virol (2002) 0.84
Generation and characterization of a recombinant vesicular stomatitis virus expressing the glycoprotein of Borna disease virus. J Virol (2007) 0.84
Borna disease virus phosphoprotein represses p53-mediated transcriptional activity by interference with HMGB1. J Virol (2003) 0.83
Failure to detect borna disease virus antibody and RNA from peripheral blood mononuclear cells of psychiatric patients. Psychiatry Investig (2009) 0.83
Borna disease virus P protein affects neural transmission through interactions with gamma-aminobutyric acid receptor-associated protein. J Virol (2008) 0.82
Borna disease virus RNA detected in Japanese macaques (Macaca fuscata). Primates (2007) 0.82
Expression of tissue factor is increased in astrocytes within the central nervous system during persistent infection with borna disease virus. J Virol (1996) 0.82
High-dose Borna disease virus infection induces a nucleoprotein-specific cytotoxic T-lymphocyte response and prevention of immunopathology. J Virol (2001) 0.82
Borna disease virus persistence causes inhibition of glutamate uptake by feline primary cortical astrocytes. J Virol (2000) 0.79
Identification of RNA instability elements in Borna disease virus. Virus Res (2009) 0.79
Antiviral CD8 T cells recognize borna disease virus antigen transgenically expressed in either neurons or astrocytes. J Virol (2008) 0.78
Borna disease in a free-ranging lynx (Lynx lynx). J Clin Microbiol (2000) 0.78
Varied persistent life cycles of Borna disease virus in a human oligodendroglioma cell line. J Virol (2002) 0.78
Persistent borna disease virus infection confers instability of HSP70 mRNA in glial cells during heat stress. J Virol (2005) 0.77
Borna disease virus possesses an NF-ĸB inhibitory sequence in the nucleoprotein gene. Sci Rep (2015) 0.77
Exacerbation of chronic inflammatory diseases by infectious agents: Fact or fiction? World J Diabetes (2010) 0.77
Two major histocompatibility complex class I-restricted epitopes of the Borna disease virus p10 protein identified by cytotoxic T lymphocytes induced by DNA-based immunization. J Virol (2003) 0.77
Glutamate and lipid metabolic perturbation in the hippocampi of asymptomatic borna disease virus-infected horses. PLoS One (2014) 0.76
Synaptic Plasticity and Neurological Disorders in Neurotropic Viral Infections. Neural Plast (2015) 0.75
Sero-epidemiological analysis of vertical transmission relative risk of Borna disease virus infection in dairy herds. J Vet Med Sci (2016) 0.75
Pathogenic potential of borna disease virus lacking the immunodominant CD8 T-cell epitope. J Virol (2007) 0.75
A novel intranuclear RNA vector system for long-term stem cell modification. Gene Ther (2015) 0.75
Biophysical and biochemical characterization of five animal viruses with bisegmented double-stranded RNA genomes. J Virol (1979) 2.39
Purification and properties of an intranuclear virus-specific antigen from tissue infected with Borna disease virus. J Gen Virol (1986) 1.51
Infectious bursal disease virus. Curr Top Microbiol Immunol (1980) 1.42
Recognition of viral antigens by human influenza A virus-specific T lymphocyte clones. J Immunol (1985) 1.40
Structural and growth characteristics of infectious bursal disease virus. J Virol (1976) 1.37
The genome of infectious bursal disease virus consists of two segments of double-stranded RNA. J Virol (1979) 1.35
The glycoprotein of influenza C virus is the haemagglutinin, esterase and fusion factor. J Gen Virol (1988) 1.33
Effect of specific antibodies on biological functions of the envelope components of Newcastle disease virus. Virology (1974) 1.31
The significance of influenza virus neuraminidase in immunity. J Gen Virol (1974) 1.30
Influenza viruses, cell enzymes, and pathogenicity. Am J Respir Crit Care Med (1995) 1.28
On the structure of the influenza virus envelope. Virology (1972) 1.27
Binding of ribonucleic acids to the RNP-antigen protein of influenza viruses. J Gen Virol (1971) 1.22
Detection of a novel Borna disease virus-encoded 10 kDa protein in infected cells and tissues. J Gen Virol (1997) 1.19
Phosphopeptide fingerprints of nucleoproteins of various influenza A virus strains grown in different host cells. J Gen Virol (1985) 1.14
Inhibition of herpes virus-induced cell fusion by concanavalin A, antisera, and 2-deoxy-D-glucose. J Virol (1974) 1.14
Structure of simian virus 40. V. Localization of the C-type polypeptide chains. Virology (1971) 1.12
Immunogenic properties of the small chain HA2 of the haemagglutinin of influenza viruses. J Gen Virol (1984) 1.12
Nucleotide sequence of infectious bursal disease virus genome segment A delineates two major open reading frames. Nucleic Acids Res (1989) 1.12
Effect of Concanavalin A on cells infected with enveloped RNA viruses. J Gen Virol (1972) 1.11
Structural and growth characteristics of two avian reoviruses. Arch Virol (1975) 1.11
Properties of RNA polymerase activity associated with infectious bursal disease virus and characterization of its reaction products. Virus Res (1987) 1.09
Properties of the infectious bursal agent of chicken (IBA). Med Microbiol Immunol (1972) 1.06
Interactions of concanavalin A with the membrane of infleunza virus infected cells and with envelope components of the virus particle. Z Naturforsch B (1972) 1.00
Biochemical studies on the cytopathic effect of influenza viruses. J Gen Virol (1967) 0.99
Action of acridines on RNA and protein synthesis and on active transport in chick embryo cells. Biochim Biophys Acta (1966) 0.99
Inhibition of influenza RNA polymerase by specific antiserum. Virology (1971) 0.97
Analysis of virus-specific RNA species and proteins in Freon-113 preparations of the Borna disease virus. Med Microbiol Immunol (1993) 0.96
Characterization and immunological properties of influenza A virus nucleoprotein (NP): cell-associated NP isolated from infected cells or viral NP expressed by vaccinia recombinant virus do not confer protection. J Gen Virol (1990) 0.95
The genetic basis for the antigenicity of the VP2 protein of the infectious bursal disease virus. J Gen Virol (1993) 0.92
In vitro cultivation of cells from the chorioallantoic membrane of chick embryos. Med Microbiol Immunol (1975) 0.91
Infectious bursal disease of poultry: antigenic structure of the virus and control. Vet Microbiol (1992) 0.91
Formation, characterization and interfering capacity of a small plaque mutant and of incomplete virus particles of infectious bursal disease virus. Virus Res (1986) 0.90
Borna disease (BD), a slow virus infection. Biological properties of the virus. Med Microbiol Immunol (1973) 0.90
The effect of azo dyes on myxovirus neuraminidase and on virus multiplication. J Gen Virol (1968) 0.88
Antigenic relationship between the surface antigens of avian and equine influenze viruses. Med Microbiol Immunol (1975) 0.86
Induction of an arginine-rich component during infection with influenza virus. J Gen Virol (1969) 0.85
Loss of virulence in a small plaque mutant of the infectious bursal disease virus. Arch Virol (1979) 0.84
[Studies on biosynthesis and serological demonstration of ribonucleoprotein antigen of influenza viruses. II. Application of indirect hemagglutination reaction for the demonstration of RNP antigens and of envelope-specific antigens]. Z Med Mikrobiol Immunol (1971) 0.83
Heterogeneity of the antigenic site responsible for the induction of neutralizing antibodies in infectious bursal disease virus. Arch Virol (1991) 0.82
Protection of mice against an influenza virus infection by oral vaccination with viral nucleoprotein incorporated into immunostimulating complexes. Med Microbiol Immunol (1994) 0.81
[Investigations on the serological behavior of an acid extract from Brucellae with special reference to indirect hemagglutination]. Pathol Microbiol (Basel) (1966) 0.81
Immunogenic properties of ISCOM prepared with influenza virus nucleoprotein. Arch Virol (1990) 0.80
Purification of influenza virus hemagglutinin by affinity chromatography. Med Microbiol Immunol (1972) 0.79
Mapping of cross-reacting and serotype-specific epitopes on the VP3 structural protein of the infectious bursal disease virus (IBDV). Arch Virol (1995) 0.79
Isolation and purification of surface antigens from disrupted paramyxoviruses. Med Microbiol Immunol (1973) 0.78
The structural polypeptide VP3 of infectious bursal disease virus carries group- and serotype-specific epitopes. J Gen Virol (1991) 0.78
Reaction of viruses and virus-infected cells with heterophile agglutinins. Ann N Y Acad Sci (1974) 0.77
Cytoplasmic synthesis of an arginine-rich nuclear component during infection with an influenza virus. J Virol (1971) 0.76
Electron microscope study of cultured cells of the chorioallantoic membrane infected with representative paramyxoviruses. Arch Virol (1980) 0.75
Agglutination of cells infected with myxoviruses by concanavalin A. Z Med Mikrobiol Immunol (1971) 0.75
Properties of erythrocytes stabilized with sulfosalicylic acid and their use in an indirect hemagglution test with influenza virus RNP-antigen. J Immunol (1968) 0.75
Pathogenic and structural properties of wild type infectious bursal disease virus (IBDV) and virus grown in vitro. Arch Virol (1987) 0.75
[The significance of phase variation for the capillary agglutination test according to the Luoto method]. Zentralbl Bakteriol Orig (1965) 0.75
Studies on the inhibitory effect of lectins on myxo-virus release. J Gen Virol (1977) 0.75
[Investigations on the development of Aegyptianella pullorum Carpano, 1928, in the soft tick Argas (Persicargas) persicus (Oken, 1818) by means of fluorescent antibodies]. Z Parasitenkd (1969) 0.75
[Studies on biosynthesis and serological demonstration of ribonucleoprotein antigen of influenza viruses. I. Studies on biosynthesis of RNP antigen and the role of cell nucleus in its synthesis]. Z Med Mikrobiol Immunol (1971) 0.75
Virus disease as a consequence of viral pathogenicity and the anti-viral immune response. Behring Inst Mitt (1992) 0.75
Evaluation of a vaccine against infectious bursal disease in field trials. Avian Pathol (1979) 0.75
The M protein of influenza viruses has no immunizing effect. Med Microbiol Immunol (1979) 0.75
Comparative evaluation of different fixation procedures and different coupling reagents for the demonstration of influenza virus-specific antibodies by the indirect hemagglutination test. Med Microbiol Immunol (1975) 0.75
Isolation and immunogenic properties of a monomeric form of the HA1 subunit of the influenza virus haemagglutinin from infected cells. J Gen Virol (1993) 0.75
The effect of mithramycin on the multiplication of myxoviruses. J Gen Virol (1970) 0.75
[Concentration of species alien (bovine) IgG in the blood serum of foals after the intake of non-species specific colostrum preparation]. Berl Munch Tierarztl Wochenschr (1993) 0.75